9 completed. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
Follow Papulopustular Rosacea: new trials by email Literature Review of Papulopustular Rosacea trials Research Report on Papulopustular Rosacea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) DFD-29, Doxycycline, Placebo - Papulopustular Rosacea | Phase 3 | Completed | Journey Medical Corporation | 330 | 2022-03-29 | 2024-12-03 |
| A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. DFD-29, Doxycycline, Placebo - Papulopustular Rosacea | Phase 3 | Completed | Journey Medical Corporation | 323 | 2022-03-14 | 2024-12-03 |
| A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea S5G4T-1, S5G4T-2 - Papulopustular Rosacea | Phase 3 | Completed | Sol-Gel Technologies, Ltd. | 372 | 2018-06-21 | 2021-12-15 |
| A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea S5G4T-1, S5G4T-2 - Papulopustular Rosacea | Phase 3 | Completed | Sol-Gel Technologies, Ltd. | 361 | 2018-06-18 | 2021-12-14 |
| A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea FMX103 1.5% - Papulopustular Rosacea | Phase 3 | Completed | Vyne Therapeutics Inc. | 504 | 2017-09-05 | 2022-01-18 |
| A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea Reference: Metronidazole Gel 1%, Test: Metronidazole Gel 1%, Placebo Gel - Papulopustular Rosacea, Erythematotelangiectatic Rosacea | Phase 3 | Completed | bioRASI, LLC | 963 | 2015-02-01 | 2020-09-03 |
| Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea Azelaic acid foam, 15% (BAY39-6251), Vehicle foam - Papulopustular Rosacea | Phase 3 | Completed | LEO Pharma | 961 | 2012-09-01 | 2023-06-09 |
| CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study Ivermectin 1% cream, Metronidazole 0.75% cream - Papulopustular Rosacea | Phase 3 | Completed | Galderma R&D | 962 | 2012-04-01 | 2015-10-28 |
| Phase 3 Papulopustular Rosacea Study CD5024, Azelaic acid 15% Gel - Papulopustular Rosacea | Phase 3 | Completed | Galderma R&D | 688 | 2011-12-01 | 2021-02-18 |
Rosacea (9)
Skin Diseases (9) · Skin and Connective Tissue Diseases (9)
Doxycycline (2) · Metronidazole (2) · Gels (1) · Ivermectin (1) · azelaic acid (1)
Galderma R&D (2) · Journey Medical Corporation (2) · Sol-Gel Technologies, Ltd. (2) · LEO Pharma (1) · Vyne Therapeutics Inc. (1) · bioRASI, LLC (1)
United States (8) · Germany (2) · Bulgaria (1) · Canada (1) · Czechia (1) · France (1) · Hungary (1) · Poland (1) · Romania (1) · Russia (1) · Ukraine (1) · United Kingdom (1)
Srinivas R Sidgiddi, M.D. (2) · Michael Graeber, M.D. (1)